Nature's Sunshine Products, Inc.
NATRConsumer DefensiveNASDAQPackaged Foods
Scan Results
Daily timeframeNature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and. At a $246.7M market cap, Nature's Sunshine Products, Inc. ranks as a micro-cap company within consumer defensive. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system.
Market Cap
$246.7M
Beta
0.85
P/E (TTM)
14.02
P/E (Fwd)
11.40
EPS (TTM)
$1.00
EPS (Fwd)
$1.23
ROE
11.2%
ROA
7.1%
Cash
$82.5M
Total Debt
$21.4M
Free CF
$16.5M
52W Change
-18.2%
Annual Financials
Cash vs Debt
Where NATR stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, NATR finished 36.93% below its 150-day moving average ($22.45) and 36.62% below its 200-day moving average ($22.34). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is NATR overbought or oversold?
At the September 3, 2026 close, NATR's RSI(14) was 27.6, in oversold territory (below 30). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Nature's Sunshine Products, Inc. holds $82.5M in cash against $21.4M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow comes in at $16.5M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 11.2% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 7.1% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $421.9M to $480.1M.
With cash comfortably exceeding debt, NATR has financial flexibility that may help navigate uncertain periods. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Nature's Sunshine Products, Inc. and its sector.